2009 annual report - faseb...faseb is a 501(c)(3) tax exempt organization of multiple member...

2009 Annual Report

The Federation of American Societies for Experimental Biology

faseb board■■ Officers

President—Mark O. Lively President-Elect—William T. TalmanPast-President—Richard B. MarchaseVice President for Science Policy—Joseph C. LaMannaTreasurer—Stanley CohenSecretary—Guy Fogleman

■■ DirectorsJoseph R. Haywood (APS)Margaret K. Offermann (ASBMB)James E. Barrett (ASPET)Peter A. Ward (ASIP)Thomas M. Badger (ASN)Mark R. Boothby (AAI)Parker B. Antin (AAA)Arthur G. Palmer (PS)Carole LaBonne (SDB)Ben M. Dunn (APEPS)Jay W. Fox (ABRF)Elizabeth Shane (ASBMR)Elizabeth McNally (ASCI)Virendra B. Mahesh (SSR)Anthony R. Scialli (TS)Henry M. Kronenberg (TES)Garry R. Cutting (ASHG)Laura Niedernhofer (EMS)John Wooley (ISCB)Carl Foster (ACSM)Shu Chien (BMES)

■■ AdvisorsJames M. Musser (ASIP)Ellen Kraig (AAI)Carrie Haskell-Luevano (APEPS)Anthony T. Yeung (ABRF)Paula H. Stern (ASBMR)Humphrey H-C. Yao (SSR)Barbara Bryant (ISCB)Frank C-P. Yin (BMES)

■■ Other Leadership PositionsImmediate Past-President for Science Policy—Avrum I. Gotlieb

Vice President-Elect for Science Policy—Judith S. Bond

Treasurer-Elect—Fred D. Finkelman

faseb Member societiesAPS The American Physiological SocietyASBMB American Society for Biochemistry and Molecular

BiologyASPET American Society for Pharmacology and

Experimental TherapeuticsASIP American Society for Investigative PathologyASN American Society for NutritionAAI The American Association of ImmunologistsAAA American Association of AnatomistsPS The Protein SocietySDB Society for Developmental BiologyAPEPS American Peptide SocietyABRF Association of Biomolecular Resource FacilitiesASBMR The American Society for Bone and Mineral ResearchASCI American Society for Clinical InvestigationSSR Society for the Study of ReproductionTS Teratology SocietyTES The Endocrine SocietyASHG The American Society of Human GeneticsEMS Environmental Mutagen SocietyISCB International Society for Computational BiologyACSM American College of Sports MedicineBMES Biomedical Engineering SocietyGSA* Genetics Society of AmericaAFMR* American Federation for Medical Research

* The FASEB Board approved GSA and AFMR memberships in December 2009; the societies became active members January 1, 2010.

All information reported as of December 31, 2009


FASEB is a 501(C)(3) tax exempt organization of multiple member societies representing tens of thousands of life scientists. In 2009, FASEB comprised 21 member societies and more than 90,000 life scientists.

FASEB Annual Report 2009 1

MISSION: The Federation of American Societies for

Experimental Biology (FASEB) advances health and welfare

by promoting progress and education in biological and

biomedical sciences through service to our member societies

and collaborative advocacy.

Table Of Contents

Board Inside Front Cover

Member Societies Inside Front Cover

President’s Report 2

Executive Director’s Report 3

Office of Public Affairs 4

The Faseb Journal 8

Summer Research Conferences 10

Minority Access to Research Careers 11

Campus Services 12

Committees 13

Awards 18

Departments 19

Services 19

Clients 19

Financial Report 20

About FASEB Member Societies 28

Credits Inside Back Cover

2 www.FASEB.org The Federation of American Societies for Experimental Biology

Many of us expected things to change after the 2008 elec-tions, but nobody could have predicted what 2009 brought in the way of challenge and opportunity. Early in the year, FASEB met with the new leadership in Congress and the Administration in a significant effort to support passage of the Fiscal Year 2009 funding bills and to have research funding included in the stimulus bill. FASEB was the first group to call for NIH funding in the stimulus legislation, and the passage of the American Recovery and Reinvestment Act (ARRA) with its substantial funding for NIH and NSF was very gratifying.

ARRA mobilized the entire biomedical research community to propose, review, and implement new projects. FASEB recognized immediately that we needed to take action so that the end of the stimulus program did not result in a funding shortfall disruptive to critical biomedical research projects. We developed a series of models to illustrate what might happen under various scenarios, brought them to the attention of the research community, and began to make the case for sustained capacity in the FY2011 NIH and NSF budgets. I met with the Deputy Director of the Office of Management and Budget to present the case for NIH, as the first step toward influencing the President’s FY2011 budget.

We continuously solicited the advice of our member societies and heard their views at their council meetings and through their representatives on the FASEB Board. As Chair of the Public Affairs Committee, I began a dialog to elicit and rank the priorities of our members. Dick Marchase and I then held meetings with nine NIH institute and center directors to urge increased funding for investigator-initiated research. I met with Francis Collins shortly after he was appointed Director of NIH, and in December he spoke at our Board meeting.

As the voice of working scientists and engineers, we took our message to Congress and the Administration via letters and meetings (including a record level of participation in our Capitol Hill Day). To strengthen the impact of our testimony on behalf of the NSF before the House Commerce, Justice, Science Appro-priations Subcommittee, FASEB arranged for Dick Marchase to be joined by leaders of the chemistry, physics, and mathematics societies in testifying before Congress. We mounted a major coalition effort to prevent a reduction in competitive research funding by helping to block a proposed increase in the Small Business Innovation Research set-aside, and our leadership on this issue was recognized by The New York Times. In October, Research Means Hope—an organization that FASEB helped to

create—launched a campaign to increase public support for biomedical research, and Judy Bond, FASEB’s Vice President-Elect, and I participated in a press conference at the National Press Club to kick off this effort.

Research funding was a high priority for us in 2009, but certainly not our only concern, as FASEB engaged in discus-sions with a wide range of regulatory agencies as part of our effort to improve the climate for research. For example, the Nuclear Regulatory Commission cited our arguments in its decision to permit researchers to continue their use of cesium-137. FASEB has also been bringing the perspective of the research community to biosecurity discussions. In July, I was invited to participate in a briefing about biosecurity for the Senate and the Weapons of Mass Destruction Commission, and in August, a FASEB staff member, Carrie Wolinetz, spoke at an FBI-AAAS-hosted meeting about synthetic biology and biosecurity. We organized a coalition letter in opposition to the Great Ape Protection Act, which would prohibit all research using chimpanzees, and worked closely with FASEB member societies and other groups to protect animal researchers from attacks by extremists.

FASEB and the biomedical research community ended the year much stronger than we began it. NIH and NSF received historic funding increases, and it was clear that the Obama Administration and Congress recognized that research was essential to our nation’s future. Despite enormous economic setbacks, our nation’s leaders remained committed to investment in research. FASEB’s contribution to this has been significant and is recognized by policymakers. As FASEB President, I was part of a select group of research advocates invited to hear President Obama speak at NIH. Our effec-tiveness comes from our large, diverse membership, and we appreciate the support of our member societies. We were also very pleased that two new groups, Genetics Society of America and American Federation for Medical Research, joined us at the end of the year.

President’s ReportMark o. lively

Many of us expected things to change after the 2008 elections, but nobody could have predicted what 2009 brought in the way of challenge and opportunity.

executive Director’s Report

…we have every reason to be confident in the value and long-term sustainability of our Federation.


Guy FoGleMan

FASEB continued to prosper during 2009, in spite of the fact that the country was in the midst of the most severe economic downturn since the 1930s. In December, the FASEB Board voted to admit two new members: Genetics Society of America and American Federation for Medical Research. Both became members on January 1, 2010. In addition,

FASEB departments signed contracts with new clients to provide services in publications, accounting, and meeting management. We demonstrated progress, described in detail in this Annual Report, in implementing FASEB’s Strategic Map. Our Strategic Map directs FASEB to promote optimal funding for biological and biomedical research, improve the climate for research, expand the community that FASEB repre-sents, provide value for FASEB societies and their members, and strengthen the effectiveness and sustainability of the Federation. The Office of Public Affairs, in particular, has been working to implement many aspects of our Strategic Map, and FASEB managers use the Strategic Map to report progress to the Board.

Our Treasurer, Stanley Cohen, established a new Investment Subcommittee of the Finance Committee to review FASEB’s investment strategy and performance. This subcommittee analyzed proposals from prospective investment managers, and the Finance Committee and Board approved the subcommittee’s recommendation to transfer FASEB’s investments to the Royal Bank of Canada. The subcommittee’s recommendations for updating our investment policy statement were also approved. FASEB’s comptroller and department heads worked with me to develop a mathematical model of our operational budget

that can be used to analyze budget scenarios a number of years into the future and under a variety of assump-tions. This model will be updated annually, and projections will be presented to the Finance Committee and Board in the spring of each year. The modeling showed that under a range of realistic assumptions, FASEB has adequate income streams and resources to cover principal payments on its debt without long-term reliance on withdrawals from reserve funds. We also used this model to assess our business lines: meetings, publications, campus, and asso-ciation management.

We continued implementation of the 5-year campus capital plan and made significant progress on the projects approved by the FASEB Board. The Campus Services Department completed the Fitness Center and numerous other projects in the Lee Building and the Beaumont House. The Information Technology Department completed rewiring the campus with updated Ethernet cabling. We developed a detailed Crisis Management/Business Conti-nuity Plan and conducted crisis management training and simulation sessions involving all department heads. This preparation was timely, as we were soon tested, in December 2009 and February 2010, with record snowstorms. The Board was pleased to renew the contract with The Faseb Journal’s Editor-in-Chief, Gerald Weissmann, for 3 additional years. Our newly redesigned website, which was developed during 2009 but went “live” in January 2010, is more intuitive to navigate, has a more modern look and feel, and provides

a good foundation for continued future improvements. As FASEB’s 2012 centennial approaches, we have every reason to be confident in the value and long-term sustainability of our Federation.

FASEB continued to prosper during 2009, in spite of the fact that the country was in the midst of the most severe economic downturn since the 1930s.


Office of Public affairs

advocacy for biomedical research and shaping of related policies on behalf of working scientists are the chief missions of the FaSeB office of Public affairs (oPa). in collaboration with FaSeB leadership, member society staff, government officials, and advocacy partners, the oPa staff facilitates a productive exchange among the scientific community, the Federal government, and the public. FaSeB’s reputation as the voice of the biomedical research community is such that when issues related to science arise, legislators, federal agencies, and other organizations come seeking FaSeB’s views.

■■ FASEB —A Strong Voice for Biomedical Research: 2009 in Review

It proved to be an interesting year for funding of federal science agencies, as the National Institutes of Health (NIH), National Science Foundation (NSF), and Department of Energy (DOE) became the recipients of federal stimulus dollars aimed at creating and maintaining jobs, spurring economic activities, and investing in long-term growth.

FASEB was a leader in advocating for stimulus funding and the increases received by science agencies in the FY2010 appropriations bills. The Federation explored new, inno-vative approaches to advocacy in 2009, while continuing to represent the biomedical research community on emerging and ongoing initiatives in science policy, such as federal funding, the use of animals in research, research training, conflicts of interest, biosecurity, and other policy issues of crucial importance to the scientific community.

■■ Science and the Stimulus: FASEB Leads Support for Extraordinary Funding

The year began with great anticipation, as Congress debated and passed a $787 billion economic stimulus package, the American Recovery and Reinvestment Act (ARRA), which included $10.4 billion for NIH, $3 billion for NSF, and $1.6 billion for DOE’s Office of Science. In late 2008, in discus-sions with the Obama Administration transition team, the advocacy community, and Congress, FASEB was one of the first groups to raise the idea of including science funding in the stimulus. As the stimulus package moved forward, FASEB worked tirelessly to maintain science funding in the final bill, meeting with congressional leadership, appropriators, and NIH champion, Senator Arlen Specter, as well as generating more than 8,000 messages in support of research funding in the stimulus. When a Senate amendment threatened to remove NSF funding from ARRA, FASEB mobilized grassroots support, contributing to the defeat of the measure.

Hope. This effort originated with a FASEB-led initiative to develop new messaging strategies for NIH advocacy and evolved into a sophisticated public opinion testing and advertising program. In targeted districts of key members of Congress, as well as in the nation’s capital, Research Means Hope ran compelling advertisements in multiple media outlets, developed thousands of followers through social media, and mobilized an outpouring of letters to Congress. FASEB President, Mark Lively, and FASEB Vice President-Elect, Judith Bond, participated in a high-profile event at the National Press Club that included speeches by patient advocates and PhRMA President, former Congressman Billy Tauzin. The Research Means Hope campaign was recognized by PR News in its 2009 Nonprofit Advocacy Awards, receiving honorable mentions in three categories: advocacy campaign and lobbying; social media; and public affairs management.

■■ Engaging Scientists in Policy and Advocacy

One of FASEB’s strengths is its ability to mobilize scientists on critical science policy and advocacy issues through use of new tools and electronic media. FASEB expanded its outreach to the scientific community this year through creation of a Congressional Visit Toolbox (http://www.faseb.org/Policy-and-Government-Affairs/Advocacy-on-Capitol-Hill/Take-Action/Congressional-Visit-Toolbox.aspx), which comprises resources


Following passage of ARRA, FASEB quickly realized the challenge that the additional funding would present to the research enterprise when the stimulus monies expired in 2011. OPA Director, Howard Garrison, developed models to forecast the consequences for biomedical research following ARRA, which were shared in high-level meetings with the Office of Management and Budget, discussed amongst the advocacy community, and released in a report to national press. In addition, FASEB took the discussion of ARRA spending and preparing for the following fiscal year straight to those with decision-making authority, meeting with a dozen NIH institute directors in early summer.

■■ Successful Advocacy for Science Funding in FY2010

To help mitigate the abrupt decline in research funding following expiration of ARRA, FASEB launched a major and successful effort to maximize research funding in the FY2010 appropriations bills. FASEB organized joint testimony with the presidents of FASEB and American chemical, physical, and mathematical societies before a House Appropriations Subcommittee in support of NSF funding. As a result of our congressional testimony, dozens of meetings with members of Congress and their staff, and active participation of FASEB society scientists in contacting their legislators, every science agency for which FASEB advocates received a significant increase in FY2010. This was an especially strong year for FASEB’s grassroots mobilization, as the Federation issued 21% more legislative alerts than the previous year, generating thousands of additional letters to Congress in support of research funding. Furthermore, FASEB took a strong leadership role in 2009 advocacy for the USDA’s competitive grants program, the Agriculture and Food Research Initiative, an effort that culminated in a nearly 32% increase in program funding and elicited public praise for FASEB by USDA leadership.

■■ Research Means Hope: Generating Public Excitement for Medical Research

FASEB joined forces with the Association of American Medical Colleges, Johns Hopkins University, the Asso-ciation of American Universities, and the Association of Public and Land-grant Universities, as well as other research stakeholders, in launching an innovative public relations campaign in support of medical research, Research Means

niH Director FranciS collinS (leFt) SPeakS witH FaSeB PreSiDent Mark lively at tHe DeceMBer BoarD MeetinG

http://www.faseb.org/Policy-and-Government-Affairs/Advocacy-on-Capitol-Hill/Take-Action/Congressional-Visit-Toolbox.aspx




and guidance to scientists for a successful visit with legis-lators in their home districts or on Capitol Hill. The Toolbox was widely praised at its launch and has been adopted for use by other organizations, including the American Psycho-logical Association, the Huntington’s Disease Society, and research institutions such as The Scripps Research Institute, the Salk Institute, and the University of California, San Diego. In addition, FASEB released an NSF Advocacy Clear-inghouse (http://www.nsfadvocacy.org/), compiling infor-mation related to the agency for use by the NSF advocacy community, policymakers, and the general public interested in learning more about NSF and the pioneering scientific research and education programs it supports. These new tools complement FASEB’s ongoing and updated electronic resources, including an NIH Advocacy Clearinghouse and data resources about federal funding trends and training and career development of the biomedical research workforce. This latter resource received a great deal of attention in 2009 and was featured in a special issue of the NCI Cancer bulletin,

as well as used by the Howard Hughes Medical Institute and other groups in policy publications and discussions.

FASEB also reached out to newer and larger audiences by launching social media pages through Twitter and

Facebook, which not only have tremendous potential to attract new audiences but also provide more opportu-nities for scientists and engineers to stay in touch and get involved with science policy issues and advocacy. Hundreds of followers and fans now receive FASEB’s daily tweets and postings. Among FASEB’s most popular resources developed in 2009 was a resource guide for investigators and institu-tions to help them understand their responsibilities under the federal Freedom of Information Act (FOIA) and state open records laws and to respond to requests for grant information filed under these statutes by animal rights groups. Created in response to a tide of threats, violence, and harassment targeting biomedical researchers, Responding

to FOIa Requests: Facts and Resources was generated through a partnership with the National Association for Biomedical Research and the Society for Neuroscience.

■■ The Voice of Biomedical Research: Scientists, Congress, and the Public

Biomedical scientists and engineers are in need of FASEB’s effective voice, now more than ever, to represent their interests to policymakers and the public. FASEB’s commu-nication activities are threefold: bringing the perspective of science to lawmakers; keeping the research community informed on science policy issues; and conveying to the general public the importance of biomedical research. FASEB continues to enjoy the success of our breakthroughs

in bioscience series, illustrated articles written at the level of a non-scientist that explain how basic research results in medical advancement. This year saw an article published about bone grafts and bone bioengineering. FASEB leaders were widely quoted in national publications and heard on syndicated radio shows, such as ReachMD. As a way to keep scientists informed about the events in Washington and facilitate their involvement in research advocacy, FASEB created a customizable poster for scientists to present at society meetings, a product that has now been used at conferences throughout the country.

MORE FUNDING TODAY. MORE MIRACLES TOMORROW.A message from patients and the physicians and researchers of America’s medical schools, teaching hospitals, universities, research companies and organizations.

ResearchMeansHope.org

Tell your members of Congress that you support significant, annual increases in medical research funding.Go to ResearchMeansHope.org to send your message today.

Treatment for Alzheimer’s

Cure for diabetes

Cure for breast cancer

Protection against cervical cancer

_

_

_

_

And today its promise has never been greater. But despite

the considerable progress that’s been made in new treatments and therapies, too many South Carolinians still suffer from

heart disease, asthma, depression, Parkinson’s and other incurable diseases. We can change this – through significant,

annual increases in federal funding for medical research. It’s one of the best investments we can make in our future.

Medical research is the beginning of hope.

FaSeB BoarD MeMBer Ben Dunn (riGHt) exPlainS How FaSeB HelPS workinG ScientiStS

…every science agency for which FASEB advocates received a significant increase in FY2010.

http://www.nsfadvocacy.org/


Behind the Scenes—office of Public affairs Staff

ManaGeMent

Howard Garrison, Director, is responsible for overall coordi-nation and direction of public policy advocacy activities.

Kim Ngo, Public Affairs Assistant, organizes communications with FASEB Board, committees, and societies.

ScientiFic aFFairS anD PuBlic relationS

Carrie Wolinetz, Director of Scientific Affairs and Public Relations, manages the breakthroughs in bioscience series and serves as primary contact for issues relating to stem cell research, biosecurity, animal research, international issues, and USDA, as well as developing and implementing communications practices.

Jennifer A. Hobin, Associate Director for Scientific Affairs, is the lead staff person on policy and legislative issues related to graduate and postdoctoral training, clinical research, peer review, and evolution education. She also serves as the staff liaison to the Science Policy Committee and Training and Career Opportunities, Clinical Research, and Peer Review Subcommittees.

Tyrone Spady, Science Policy Analyst, specializes in issues related to research information technology, NIH portfolio balance, and fundamental biological research. He staffs

the recently formed Research Information Technology Subcommittee of the Science Policy Committee, as well as the NIH Portfolio Management Subcommittee.

Lawrence Green, Communications Specialist, is responsible for managing many of the electronic communications developed by OPA, including serving as the contact person for the website, media relations, and electronic presentation of advocacy materials.

leGiSlative aFFairS

Jennifer Zeitzer, Director of Legislative Relations, directs the FASEB Capitol Hill Office and represents FASEB in communications with the U.S. Congress. Moreover, she develops legislative strategies and coordinates our efforts with those of our chief legislative advocacy partners.

Kimberly McGuire, Policy Analyst, assists with the overall legislative program with responsibility for efforts pertaining to appropriations for the Department of Energy, National Science Foundation, and Department of Veterans Affairs. Her policy portfolio includes staffing the NIH Issues Subcommittee and covering conflict-of-interest issues.

office of Public affairs Publications in 2009

■▪ FASEB (2009) Federal Funding for biomedical Research and Related Life science Research—FY2010. (www.faseb.org/federalfundingreport2010).

■▪ FASEB (2009) Investing in Our Future: a stronger NIH for a Healthier america. (http://www.faseb.org/Portals/0/PDFs/opa/Investing_In_Our_Future.pdf ).

■▪ Garrison, H. H., and Ngo, K. (2009) education and employment of biological and Medical scientists: Data from National surveys (www.faseb.org/scientistseducationjobdata).

■▪ NABR, SfN, and FASEB (2009) Responding to FOIa Requests: Facts and Resources. (www.faseb.org/respondingtofoia).

■▪ Stocker, S., and Wolinetz, C. D. (2009) Bone Builders: The Science of Grafts. Biomaterials, and Bone Engineering, breakthroughs in bioscience, 26. (www.faseb.org/bonebuildersbreakthroughs).

■▪ Wolinetz, C. D. (February 2009) From Inside the Lab to Inside the Beltway. asbMb Today.

■▪ Wolinetz, C. D. (February 2009) New President, New Congress…New Hope for Science? The Physiologist. 52(1): 1, 3–5.

■▪ Zeitzer, J. (December 2009) NIH Director Collins Reviews Top Goals at Town Hall Meeting. aaa Newsletter.


The FASEB Journal

it is now four years since our editorial Board assumed responsibility for The FASEB Journal, and we report progress in three areas: publishing performance, impact factor and reputation, and the journal’s public face.

■■ Publishing PerformanceThe reassuring aspect of our performance has been the total number of visits to our journal in the past year: over 9.7 million hits in 2009 (vs. 4.7 million hits in 2005).

Despite a modest decrease in the total number of articles published, we now receive close to 200 initial query (IQ) submissions each month (vs. 117 in 2004). This rate is constant; we received approximately 2,300 submissions in 2009 (vs. 1,670 in 2005). We have also shortened the turnaround time between first submission and acceptance to 90 days (vs. 102 days in 2005). As a consequence, the bar to publication has been raised: we now accept no more than 17% of papers submitted (vs. 27% in 2005). This barrier has caused some dismay but has improved the quality of our submissions.

Performance of The FASEB Journal

Year Submissions Turnaround* Percent Accepted Hits on Article Content

2009 2291 90 17.5 9,729,549

2008 2060 86.9 16.9 8,594,847

2007 2154 84.4 13.0 5,671,239

2006 2024 98.8 23.2 4,826,967

2005 1670 101.9 26.9 4,741,356

2004 1581 117.3 33.5 3,899,055*Days from submission to acceptance.

■■ Impact Factor and ReputationThe Faseb Journal’s impact factor continues to increase:

Year Articles Published Citations Impact factor

2008* 413 34,300 7.04

2007 388 32,421 6.79

2006 449 30,621 6.72*Latest impact factor available from Journal Citation Reports.

We can be proud of the fact that we received 34,300 cita-tions for 413 articles published and that our impact factor was 7.04.

In 2009, the 11,000 members of the Special Libraries Association celebrated the 100th anniversary of their professional group of specialist librarians; and its Biomedical and Life Sciences Division commissioned a panel of nine international expert librarians in biological and clinical sciences to design and administer a poll asking its membership which were the 100 most influential journals in biology or medicine of the last 100 years. The Faseb Journal, competing in a crowded category of “Journals Covering Multiple Areas within Biology,” made it to the top 100, surpassing several venerable and esteemed competitors, such as the Proceedings of the Royal society of London.

The striking increase in press coverage has probably—more than any other factor—accounted for the incredible attention our journal attracts on the web.

GeralD

weiSSMann

eDitor-in-cHieF

The FASEB Journal

How VisionBegins:PhotoactivatedRhodopsinCouples withTransducin

p. 371

February 2009Vol. 23, No. 2

The Journal of the Federation of American Societies for Experimental Biology

TH

E FA

SE

BJO

UR

NA

LFE

BR

UA

RY

2009V

OL

UM

E 23, N

UM

BE

R2

PAG

ES

289-666

ISS

N 0892-6638

z380020900SPC1.qxd 1/12/09 1:21 PM Page 1

The FASEB Journal

Epigenetics:ModifyingTheHistoneCodeIn Utero

p. 2438

August 2009Vol. 23, No. 8

The Journal of the Federation of American Societies for Experimental Biology

TH

E FA

SE

BJO

UR

NA

LA

UG

US

T2009

VO

LU

ME

23, NU

MB

ER

8PA

GE

S 2337-2790

ISS

N 0892-6638

z380080900SPC1.qxd 7/14/09 11:39 AM Page 1


■■ The Public FaceThe striking increase in press coverage has probably—more than any other factor—accounted for the incredible attention our journal attracts on the web: those 9.7 million hits were generated in large part through the efforts of Cody Mooneyhan who is the journal’s Managing Editor and serves as its Public Information Officer.

Newspaper and Wire Service Pick-Ups*

0

10

20

30

40

50

60

70

80

0

20

40

60

80

100

120

2 0 8 3 4 32 8 5 35 16 3 63 36 13 79

■ Total Newspaper Pick-Ups ■ Major World Newspaper Pick-Ups ■ Wire Service Pick-Ups

* Data collected using Nexis®.

We have continued to attract the notice of a new audience on the web and in libraries. Our covers combine striking images taken from masterpieces of scientific illus-tration (Haeckel, Leuckart, Seba, Lear, Pinson, etc.) with short, newsworthy captions that spell out the cover story. Such recent headlines as “Genetically Engineered Tobacco Plant Cleans Up Environmental Toxin” or “Why BPA Leached from ‘Safe’ Plastics May Damage Health of Female Offspring” have attracted coverage in radio, television, and press worldwide.

Moreover, our frank, open, and extensive editorial positions in favor of investigator-sponsored research and evolutionary science and our opposition to faith-based science, intelligent design, dietary supplements, and “alternative medicine” have attracted wide attention. We are being read, and by a wide audience that is larger than the FASEB membership. Our editorials have been covered in the columns of science and Lancet; attracted violent reactions in the blogs of the Discovery Institute; caught the attention of homeopaths and their debunkers; and challenged Lyme disease and fibromyalgia support groups. Our Up Front section, which includes editorials, essays, and cultural reviews (e.g., the science in the Arab and Greek world and Nobel “no-shows”), is widely read. Indeed, the Up Front section boasts 15 of the 100 most-read articles of The Faseb

Journal in 2009:

#7 Falagas, M. E., Zarkadoulia, E. A., and Samonis, G. (2006) Arab science in the golden age (750–1258 C.E.) and today. Faseb J. 20, 1581–1586.

#8 Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., and Pappas, G. (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. Faseb J. 22, 338–342.

#11 Weissmann, G. (2008) Writing science: the abstract is poetry, the paper is prose. Faseb J. 22, 2601–2604.

#14 Falagas, M. E., and Kavvadia, P. (2006) “Eigenlob”: self-citation in biomedical journals. Faseb J. 20, 1039–1042.

#29 Weissmann, G. (2007) Publish or perish: letter to a young contributor. Faseb J. 21, 631–634.

#30 Weissmann, G. (2007) The experimental pathology of stress: Hans Selye to Paris Hilton. Faseb J. 21, 2635–2638.

#35 Weissmann, G. (2006) Homeopathy: Holmes, Hogwarts, and the Prince of Wales. Faseb J. 20, 1755–1758.

#39 Edelson, A. M. (2006) Nobel “no-shows”. Faseb J. 20, 3–6.#48 Weissmann, G. (2009) Walter Benjamin and Biz Stone:

the scientific paper in the age of Twitter. Faseb J. 23, 2015–2018.

#51 Falagas, M. E., Zarkadoulia, E. A., Bliziotis, I. A., and Samonis, G. (2006) Science in Greece: from the age of Hippocrates to the age of the genome. Faseb J. 20, 1946–1950.

#57 Weissmann, G. (2005) The facts of evolution: fighting the Endarkenment. Faseb J. 19, 1581–1582.

#61 Weissmann, G. (2009) The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs. Faseb

J. 23, 1279–1282.#69 Weissmann, G. (2009) Witchcraft and Reiki: voodoo

economics and voodoo healing. Faseb J. 23, 1617–1621.#87 Haas, F. (2008) German science and black racism—roots

of the Nazi Holocaust. Faseb J. 22, 332–337.#95 Weissmann, G. (2007) “Chronic Lyme” and other medi-

cally unexplained syndromes. Faseb J. 21, 299–301.

2005 2006 2007 2008 2009


summer Research Conferences

■▪ Amyloid Fibril Formation and Protein Misfolding

■▪ Autoimmunity

■▪ Ciliate Molecular Biology

■▪ Dynamic Structure of the Nuclear Hormone Receptors

■▪ Epigenetics, Chromatin, and Transcription

■▪ From Unfolded Proteins in the Endoplasmic Reticulum to Disease

■▪ Gastrointestinal Tract XIII

■▪ Genetic Recombination and Genome Rearrangements

■▪ Glucose Transporter Biology and Diabetes

■▪ Hematological Malignancies

■▪ Histone Deacetylases and Reversible Acetylation in Signaling and Disease

■▪ Intracellular RNA Transport and Localized Translation

■▪ Ion Channel Regulation

■▪ Lipid Signaling Pathways in Cancer

■▪ Lysophospholipid Mediators in Health and Disease

■▪ Mechanisms and Regulation of Prokaryotic Transcription

■▪ Microbial Pathogenesis: Mechanisms of Infectious Disease

■▪ Mitochondrial Assembly & Dynamics in Health and Disease

■▪ Mitosis: Spindle Assembly and Function

■▪ Mobile Elements in Mammalian Genomes

■▪ Molecular Mechanisms of Lymphocyte Differentiation

■▪ NAD Metabolism and Signaling

■▪ Nuclear Structure and Cancer

■▪ Proteases in Hemostasis and Vascular Biology

■▪ Protein Kinases and Protein Phosphorylation

■▪ Protein Lipidation, Signaling, and Membrane Domains

■▪ Signal Transduction in the Immune System

■▪ Smooth Muscle

■▪ TGF-β Signaling in Development and Disease

■▪ The Biology and Chemistry of Vision

■▪ The Physiological Basis for Obesity Therapeutics

2009 FaSeB Summer research conferences

the FaSeB Summer research conferences are highly-regarded programs designed to facilitate communication at the cutting edge of current research topics.

Thirty-one FASEB Summer Research Conferences were scheduled during June, July, August, and September 2009. The FASEB Summer Research Conference Advisory Committee reviews and selects conferences from proposals submitted by member and nonmember organizers. Every effort is made to avoid duplication of other conferences and topics. Emphasis is on cutting-edge research, with prominent scientists in each field making presentations to attendees who are heavily engaged in research or are in ancillary fields where an accurate understanding of allied

scientific advances is important. Postdoctorial candidates are also encouraged to participate in the conferences. Attendees are selected by the organizers on the basis of their probable contributions to science.

The conferences were held at the Vermont Academy in Saxtons River, Vermont; Snowmass Village Conference Center in Snowmass Village, Colorado; the Carefree Resort in Carefree, Arizona; and Il Ciocco in Lucca, Italy. The total atten-dance for all conferences was 3,368 with an average of 109 attendees per conference. Thirty percent of the attendees were from outside the United States.


MaRC:Minority access to Research Careers

■■ FASEB MARC Programs 2009 Activity Report

■▪ Visiting Scientists: career development seminars atminority institutions: 30 visits

■▪ Visiting Scientists: grantsmanship training seminars at minority institutions: 5 seminars

■▪ Scientific Meetings Travel Awards: 43 faculty members/mentors; 98 mentees/students; 34 peer mentors; 229 poster presenters

■▪ Grantsmanship Training Seminar Travel Awards: 2 seminars sponsored; 75 faculty members/postdoctorates/graduate students

■▪ Summer Research Conferences Travel Awards: 7 faculty members; 8 graduate students; 6 postdoctorates

■▪ Summer Research Opportunity Program Travel and Subsistence Awards: 82 students; 45 mentors; 18 host institutions

the Minority access to research careers (Marc) program was created by the national institute of General Medical Sciences, national institutes of Health (niGMS/niH) to increase the number of biomedical and behavioral scientists from underrepresented minority groups. a key objective of the Marc program is the encouragement of underrepresented minority students in the pursuit of graduate training leading to the Ph.D. degree in the biomedical sciences.

FASEB has supported the training of minority scientists for over 20 years through MARC grants that involve a variety of programs and activities including:■▪ Support for FASEB societies’ diversity program initiatives

■▪ Travel Awards for faculty and students to attend FASEB societies’ scientific meetings and conferences

■▪ Travel Awards for poster/oral presenters (students and postdoctoral fellows) to attend FASEB societies’ scientific meetings and conferences

■▪ Travel Awards for minority scientists, senior postdoctoral fellows, and graduate students to attend FASEB Summer Research Conferences

■▪ Travel/Subsistence Awards for undergraduate students to participate in summer research opportunities programs at major research institutions and universities

■▪ Sponsoring Postdoctoral Professional Development and Enrichment Awards for senior postdoctoral fellows and new assistant professors

■▪ Sponsoring grantsmanship training seminars and workshops at scientific meetings during the summer sessions, and on the campuses of minority institutions

■▪ Sponsoring faculty/student career development seminars at minority institutions

■▪ Sponsoring career development programs and activities for minority researchers and students during the Experimental Biology Annual Meeting and a select group of other FASEB societies’ meetings

■▪ Support for the FASEB MARC Program Advisory Board Annual Meeting

■▪ Hosting FASEB MARC program activities and InfoNet on the FASEB website

FASEB has supported the training of minority scientists for over 20 years through MARC grants that involve a variety of programs and activities.


Campus servicesContributing to a safe, Welcoming, and sustainable environment

■■ Healthful and Safe Environment

During 2009, Campus Services continued to forward an agenda focused on providing a safe environment to the campus community. The year saw an increased number of opportunities provided by Campus Services for staff to attend in-house automated external defibrillator/cardio pulmonary resuscitation training. In addition, increased participation of campus staff with safety-related activities was achieved through a more active Safety Warden program. Included in the enhanced safety program were the publi-cation and distribution of the Faseb Campus safety Warden Information booklet and an information session for Safety Wardens. During 2009, the FASEB management staff partici-pated in an emergency response exercise to enhance their effectiveness in the event of a real emergency.

Opportunities for more healthful lifestyles were also introduced to the campus community through programs supported by Campus Services. Early in 2009, the campus Fitness Center and adjoining locker facilities were completed and opened for use by the campus community. Approxi-mately 45% of the campus community has submitted requests for access to the fitness facility, which includes resistance and aerobic fitness equipment. In addition to the Fitness Center, campus staff was offered the opportunity to participate in on-campus yoga sessions starting in early 2009.

■■ Comfortable and Welcoming Environment

Campus Services continued to address the many capital renovation projects approved by the FASEB Board of

Directors in the 5-year capital renovation plan. Some of the projects that were completed or active in 2009 included the completion of the Fitness Center; locker/shower facilities; replacement carpeting; restroom renovation; fan coil unit replacement; air handler engineering and procurement; building automation enhancements; and server room heating, ventilation, and air conditioning system (HVAC) upgrade.

In addition to enhancements in the physical envi-ronment, Campus Services initiated enhancements to food and beverage services offered to campus staff. Increased offerings included a greater variety of foods and beverages available for purchase each morning. Lunch service was expanded to include alternative food providers throughout the work week, rather than a sole provider.

■■ Sustainable Environment Campus Services has taken opportunities for forwarding an agenda supporting a more sustainable environment. Efforts undertaken in 2009 to enhance our resource conservation and sustainable resources included altering HVAC system operations to reduce energy consumption, increased use of energy-saving initiatives such as motion detectors and more efficient lighting, recycling campus tree debris into wood chips for use in campus plant beds, using recycled green-ware for conference center functions, moving from oil-based to soy-based inks in the printing department, and reducing vehicle use by better scheduling mail services.

Opportunities for more healthful lifestyles were also introduced to the campus community through programs supported by Campus Services.

FaSeB’s historically rich Beaumont campus spans eleven lush acres in Bethesda, Maryland, not far from the national institutes of Health.


faseb CommitteesFaSeB’s strength in advocating for biomedical research is its diversity of disciplines and the large number of scientists it represents. to ensure that the views of all member societies and the researchers they represent are heard, FaSeB is guided by its Board of Directors as well as committees focused on areas such as public affairs, protection of human subjects in research, research conferences, publications, and membership.

■■ Standing Committeesexecutive committeeMark O. Lively, Chair As directed by the FASEB Bylaws, Article VII, Section 2 (available on the FASEB website), the Executive Committee is a standing committee of the Board that consists of the officers of the Board. The committee meets weekly to “exercise the management authority of the Board of Directors in between meetings of the Board of Directors.”

In 2009, with rare exceptions, the committee met weekly to review the events of the week. The Deputy Executive Director for Policy routinely participated in those meetings. The agenda was usually divided equally between issues related to advocacy by the organization and issues related to the business functions of FASEB.

The business of running FASEB is reviewed with special attention to fiscal matters, campus issues, and relation-ships with FASEB member societies. The activities of other committees of FASEB are reviewed as needed. Planning of FASEB Board meetings is also a function of this committee. The voting officer members of the Executive Committee make up the Nominating Committee and recommend a slate of candidates for election as officers of the organization.

executive coMMittee MeMBerS

Stanley Cohen Mark O. LivelyGuy Fogleman Richard B. MarchaseJoseph C. LaManna William T. Talman

executive officers advisory committeeGuy Fogleman, ChairThe Executive Officers Advisory Committee (EOAC) is a standing committee of the Board. As stated in the FASEB Bylaws, Article VII, Section 3, the EOAC “shall address itself to items of mutual interest to the Federation and the member societies.” The EOAC met 12 times in 2009 and considered a wide range of cross-cutting issues of interest to all of the societies. Subjects included:

■▪ Public affairs and legislative affairs relevant to the Federation and member societies

■▪ FASEB elections and the composition of the FASEB Board and committees for 2009/2010

■▪ Proposed amendments to the FASEB Bylaws

■▪ FASEB dues structure

■▪ Guidelines for working with minor student-volunteers and student-employees

■▪ Review of the proposed FASEB 2010 Operating and Capital Budgets

Reports of activities of each FASEB member society were presented to the EOAC for the joint purposes of information sharing and soliciting advice. The EOAC continues to review and develop positions on major issues brought to the FASEB Board.

eoac MeMBerS

Joann A. Boughman (ASHG) M. Michele Hogan (AAI)Christine K. Carrico (ASPET) Scott Hunt (TES)Ida Chow (SDB) Judith Jansen (SSR)John E. Courtney (ASN) Tonia Masson (TS) (EMS)Michelle M. Detwiler (ABRF) BJ Morrison McKay (ISCB)Ann Elderkin (ASBMR) Andrea Pendleton (AAA)Gregg B. Fields (APEPS) Edward L. Schilling (BMES)Guy Fogleman (FASEB) Mark E. Sobel (ASIP)Martin Frank (APS) James R. Whitehead (ACSM)Barbara A. Gordon (ASBMB) Cynthia A. Yablonski (PS)John B. Hawley (ASCI)

Finance committeeStanley Cohen, Treasurer and ChairThe Finance Committee, in consultation with the Executive Director, is responsible for recommending an annual budget to the Federation Board; safeguarding the invested funds of the Federation; recommending an investment policy for the


Federation (subject to approval by the Federation Board); and in all other ways, assisting the Treasurer.

During 2009, the Finance Committee took the following actions:■▪ Approved the 2008 Audited Financial Statement

■▪ Accepted the Investment Subcommittee’s recommendation to contract RBC Wealth Management as FASEB’s investment manager and presented the recommendation to the Board of Directors, which accepted the recommendation

■▪ Charged the Executive Director, in collaboration with the Membership Committee, to develop possible alternative dues structures for discussion

■▪ Approved a revised Investment Policy Statement

■▪ Approved the 2010 Operating and Capital Budgets

Finance coMMittee MeMBerS

Stanley Cohen* Richard B. Marchase*William Coleman Bruce D. MurphyFred D. Finkelman Merle S. OlsonDavid G. Gardner Jeffrey L. SchwartzGregory A. Grant William T. Talman*Duane E. Haines Jean-Francóis TombRichard A. Hawkins Kathryn W. TosneyMark C. Horowitz Lynn WeckerMark O. Lively* *FASEB Board Member

Membership committeeJeffrey L. Schwartz, ChairThe Membership Committee is charged to make recommendations regarding membership in FASEB. Specifically, the charge to the committee is to: 1) review applications for FASEB membership and report to the Board the conclusions of their deliberations; 2) make recommendations to the Board regarding membership criteria; 3) make recommendations of candidate organizations that should be approached regarding possible FASEB membership; 4) address issues of membership retention and membership admission; and 5) address any other topics related to FASEB membership.

The committee made significant strides in 2009 by increased communications with potential and current member societies. At the December 2009 Board of Directors Meeting, the Board unanimously approved the committee’s recommendation to accept Genetics Society of America (GSA) and American Federation for Medical Research (AFMR) for FASEB membership, effective January 1, 2010.

The committee also held detailed discussions regarding membership dues levels, alternative dues approaches, and optimal size of membership for the future.

MeMBerSHiP coMMittee MeMBerS

Parker B. Antin* Richard B. Marchase*John M. DeSesso Jeffrey L. Schwartz Carl Foster* William T. Talman*Martin Frank Peter A. Ward*Mark O. Lively* *FASEB Board Member

Public affairs committeeWilliam T. Talman, ChairThe Public Affairs Committee (PAC), which is made up of the members of the Executive Committee together with two Board members elected annually, meets monthly to advise the Office of Public Affairs on emerging issues. The PAC also meets in person twice a year to discuss long-term public affairs priorities for the Federation. At the committee’s May meeting, the PAC discussed the advocacy priorities of FASEB and its member societies, as expressed in the responses to a letter from Mark Lively. The committee also proposed a FASEB conference on translational research as a way to initiate a dialog between basic and clinical scientists. In November, the PAC discussed ways to improve the flow of information between FASEB and its member societies, endorsed an inter-national conference on combating animal rights extremism, asked OPA staff to create a website featuring member society education initiatives, and discussed economic arguments in support of biomedical research.

Pac MeMBerS

Judith S. Bond* Mark O. Lively*Stanley Cohen* Richard B. Marchase*Ben M. Dunn* Margaret K. Offermann*Avrum I. Gotlieb* William T. Talman*Joseph C. LaManna* *FASEB Board Member

Science Policy committeeJoseph C. LaManna, ChairThe Science Policy Committee (SPC) is FASEB’s “think-tank” and is charged with developing long-term policies and consensus positions on issues of concern to biomedical researchers. Avrum I. Gotlieb, FASEB’s Vice President for Science Policy, completed his term as chair of the SPC on June 30 and was succeeded by Joseph C. LaManna. Working through its nine subcommittees, the SPC was actively engaged in a wide variety of policy issues critical to biomedical scientists and engineers in 2009. The highlights of the SPC’s activities are detailed below.


MaintaininG leaDerSHiP on key Policy iSSueS

Improving the Climate for ScienceWith scientists spending a considerable amount of their time on administrative and regulatory activities, reducing regulatory burden continues to be a focus of the SPC and its subcommittees. Taking a broad approach to the issue, FASEB sent a letter to the U.S. Office of Management and Budget, urging the agency to ensure that the additional cost and time associated with new regulations are balanced by meaningful improvements to the current oversight system. In addition, the Federation recommended harmonizing regulations to avoid the duplication and inconsistencies that so often hamper research progress.

FASEB’s Clinical Research, Biosecurity, and International Issues Subcommittees have been among the most active in addressing specific regulatory concerns. The Clinical Research Subcommittee advocated for changes to human subjects protection regulations that would reduce barriers to conducting multi-center human research projects and proposed improvements to the process of accrediting human research protection programs. FASEB was pleased to see several of our recommendations incorporated into the final accreditation standards.

The year saw a flurry of activity related to federal over-sight of the use of biological pathogens in research; the SPC’s Biosecurity Subcommittee made certain that the voice of the research community was part of this discussion. The subcommittee developed a host of recommendations for improving the framework governing the use of these agents, many of which were adopted by the federal working group charged with strengthening U.S. biosecurity. FASEB also took the lead in urging the U.S. Senate to delay action on a bill that would have created a redundant system of regulations for controlled pathogens and potentially inhibited important human health and biodefense research.

The regulation of the entry of international scholars into the United States to facilitate scientific exchange remains of concern to the scientific community. Under the guidance of the International Issues Subcommittee, FASEB joined with other scientific organizations and university groups in issuing recommendations to alleviate visa processing delays experienced by international students, scholars, and scientists who have applied to study, conduct research, or attend conferences in this country.

Optimizing Research SupportThe SPC contributes to FASEB’s advocacy agenda regarding policies that would optimize support for biomedical

research. When Francis Collins assumed the role of NIH Director in 2009, the NIH Issues Subcommittee took the opportunity to share our perspective on the agency’s research portfolio with the new director, encouraging NIH to shore up support for investigator-initiated research, and maintain balance among basic, clinical, and translational research funding. Optimization of the peer review system was also a SPC priority in 2009. In a letter to NIH’s Center for Scientific Review, the Federation encouraged the agency to revise its resubmission policy, improve the training of reviewers and staff, and evaluate the effectiveness of proposed review mechanisms before broadly implementing new policies and procedures.

Enhancing Scientific Education and TrainingScientific training remains a key focus for the SPC. With concerns about the misuse of biological pathogens on the rise, the Biosecurity Subcommittee led FASEB in publishing its first statement about dual-use research awareness and biosecurity education. The statement proposed integrating biosecurity education into responsible conduct of research training and included recommendations as to how the Federal government and training institutions could support the development of an appropriate training curriculum.

Furthermore, FASEB’s Training and Career Opportunities Subcommittee took up the issue of responsible conduct of research education, recommending in a letter to the National Science Foundation that all undergraduates, graduate students, and postdoctoral scientists engaged in research receive such training. The subcommittee also released a statement calling on all investigators to develop plans for training and mentoring postdoctoral scholars supported on their research grants and has been working to create tools to help trainees develop their own career and professional development plans.

Ensuring Access to Animals for ResearchThanks to the work of the Animals in Research and Education Issues Subcommittee, FASEB continues to lead in main-taining public support for the use of animals in research. We marshaled community opposition to the Great Ape Protection Act, a bill that would end medical research on great apes and halt research aimed at developing cures for devastating diseases such as hepatitis C and HIV/AIDS. FASEB also requested that the U.S. Senate remove bill language that would prohibit federal grants or contracts involving animals supplied by Class B dealers. If enacted, this provision could disrupt medical progress in important areas of scientific inquiry such as cardiovascular research.


MovinG in new Policy DirectionS

With the advancement of new research technologies, scientists are generating more data, and more complex data, than ever before. At the same time, federal efforts to create an integrated electronic health information network have the potential to generate vast amounts of health information that will be invaluable to biomedical researchers. Enabling the infrastructure to collect, store, and analyze these data, as well as the policies to allow researchers to use this information responsibly, will be essential for maximizing our nation’s research investments. To ensure that FASEB has a voice in these exciting new developments, the SPC formed a new subcommittee in 2009: the Research Information Technology Subcommittee, chaired by John Wooley, will represent our member societies on issues related to information technology and data accessibility.

SuBcoMMitteeS oF tHe Science Policy coMMittee

■▪ Animals in Research and Education Issues, Kevin Kregel, Chair

■▪ Biosecurity, Avrum I. Gotlieb, Chair

■▪ Breakthroughs in Bioscience, James E. Barrett, Chair

■▪ Clinical Research, Richard Galbraith, Chair

■▪ International Issues, Larry Suva, Chair

■▪ NIH Issues, Mark R. Boothby, Chair

■▪ Peer Review, Gail Bishop, Chair

■▪ Research Information Technology, John Wooley, Chair

■▪ Training and Career Opportunities, Louis B. Justement, Chair

SPc MeMBerS

Thomas M. Badger* Avrum I. Gotlieb*Judith S. Bond* Louis B. JustementStanley Cohen* Claudia KappenGarry R. Cutting* Joseph C. LaManna*Ben M. Dunn* Mark O. Lively*Steven I. Dworkin Richard B. Marchase*Joanne Fortune William A. MullerCarl Foster* Michael A. PortmanJay W. Fox* Sharma S. PrabhakarJonna M. Frasor

William M. Reichert Paula H. SternPeter A. Rubenstein William T. Talman*Gina C. Schatteman Graciela A. UnguezJeffrey L. Schwartz John Wooley*

*FASEB Board Member

Publications and communications committeeAndrew J. Young, ChairThe FASEB Publications and Communications Committee (PCC) met in April 2009 and received a report from FASEB’s Executive Director, a communications update from the FASEB Office of Public Affairs, and several reports relating to The

Faseb Journal (FJ). A review committee was formed earlier in the year to evaluate the performance of Gerald Weissmann as Editor-in-Chief of FJ. The PCC heard the report and recom-mendation from the Advisory Committee. Members of the PCC discussed the Editor-in-Chief’s performance and later provided some feedback to Dr. Weissmann in a letter from the PCC Chair. At the meeting, a motion was made, seconded, and approved unanimously that the PCC would recommend to the FASEB Board a 3- to 5-year extension on Dr. Weissmann’s contract. Other key issues discussed at the PCC meeting included a review of the journal’s scientific misconduct policy and the Editorial Board’s concern about publishing meeting abstracts in the journal.

Pcc MeMBerS

James U. Bowie Edward T. MorganMichael W. Deem Yvonne PatersonLorraine Fitzpatrick William G. Stetler-StevensonLouis C. Gerstenfeld Belen TornesiDavid Gutterman Michiko WatanabeRobert H. Heflich Susan T. WeintraubAlan L. Johnson Gerald WeissmannScott Markel Andrew J. YoungJasna Markovac

■■ Ordinary Committees

Protection of Human Subjects committee

Guy Fogleman, ChairThe Protection of Human Subjects Committee (PHSC) was established by the FASEB Board of Directors in 2008 per a recommendation of the Office for Human Research Protections (OHRP). The committee is authorized to determine whether a FASEB member society program


involving surveys that evaluate educational programs and other social science endeavors is exempt from IRB review [under HHS regulations at 45 CFR 46.101(b)]. The committee ensures the appropriate communication of such a policy to all investigators.

In 2009, the committee exempted seven proposals from IRB review.

PHSc MeMBerS

Joann A. Boughman Martin Frank Guy Fogleman Mark E. Sobel

excellence in Science award committee Margaret K. Offermann, ChairThe Excellence in Science Award Committee (ESAC) reviews nominee submissions and makes a recommendation of the recipient to the Board of Directors. The committee advises the Board on the administration of the annual Excellence in Science Award program.

eSac MeMBerS

Wylie Burke Sally A. MoodyLaurel H. Carney Margaret K. Offermann*Nancy D. Denslow Carol A. ParonisBonnie N. Dittel Jane F. ReckelhoffBarbara S. Durrant Neena B. Schwartz Carrie Haskell-Luevano Judith M. VenutiBarbara E. Kream Dani S. ZanderHenry M. Kronenberg* *FASEB Board Member

Sponsored continued Medical education committee Guy Fogleman, ChairIn July 2008, FASEB was reaccredited by the Accreditation Council for Continuing Medical Education (ACCME) to certify CME activities for FASEB member societies. With support from the Executive Officer’s Advisory Committee, the FASEB Board created the Sponsored Continued Medical Education Committee (SCMEC) in September 2008 with the purpose of reviewing CME applications submitted by the five partici-pating member societies and determining whether the applications meet all requirements as set forth in the ACCME and FASEB guidelines. Following the society’s CME activity, the committee reviews the sponsored CME final report to ascertain full compliance with all guidelines. A year later, we have four FASEB members participating on the committee.

Since September 2009, the SCMEC reviewed and approved five CME program proposals.

ScMec MeMBerS

Joann A. Boughman Guy FoglemanJohn E. Courtney John HawleyAnn Elderkin Mark E. Sobel

Summer research conferences advisory committeeRobert D. Blank, ChairThe FASEB Summer Research Conferences (SRC) Advisory Committee is made up of one person from each member society who is appointed by the member society’s Executive Officer. Each committee member’s term is 3 years. The chair of the committee is selected by the Board from among the committee members. Robert D. Blank of ASBMR was appointed chair for 2009–2010.

The immediate responsibility of the committee is to determine the conference topics and organizers for the conference series that will take place in 2 years (i.e., the conferences reviewed in 2009 will take place in 2011). It shall also be responsible for recommending policies and stan-dards for the conduct of the conferences. The committee meets once annually in the fall by conference call. Ad hoc meetings are scheduled on an as-needed basis.

The summer of 2009 was the fourth time conferences were organized and held in Italy. The Italian venue is steadily becoming popular, as it appeals to many Europeans who are unable to attend conferences held stateside. The Snowmass Village venue has remained the most popular venue. Because of the Snowmass Village’s popularity, the FASEB SRC Advisory Committee has secured a second venue in Colorado. Vermont Academy still remains popular among the conference participants.

Src aDviSory coMMittee MeMBerS

Jack Bergman Sidney GolubDaniel J. Bernard Gerald B. GrunwaldRobert D. Blank Dale “Buck” HalesGeorge M. Carman Carole LaBonne*Kevin L. Gardner Michael LovettLila M. Gierasch Stephen J. MoormanLaura T. Goldsmith Laura Niedernhofer*

*FASEB Board Member


faseb awardsat FaSeB we take great pride in the accomplishments of our member societies, as well as those of the entire scientific community. to celebrate the efforts of those working to advance biological and biomedical sciences, FaSeB gives two types of awards each year to individuals making a difference.

■■ Excellence in Science AwardThe Excellence in Science Award has been sponsored by Eli Lilly and Company since 1989 to recognize outstanding achievement by women in biological science. All women who are members of one or more of the FASEB societies are eligible for nomination. The award recognizes a woman whose career achievements have contributed significantly to further understanding of a particular discipline by excellence in research and who is an outstanding mentor for young scientists at all levels of development.

2009 excellence in Science award winner Susan l. lindquist

Dr. Lindquist’s focus on protein-folding mechanisms has led to paradigm-shifting discoveries in stress

tolerance, gene regulation, evolution, and human protein-folding diseases. She is a pioneer in the molecular analysis of the heat-shock response, providing definitive evidence that each heat-shock protein solves a different aspect of stress tolerance and protein-folding. She has changed our notions of how an organism’s environment influences the phenotypic expression of natural genetic variation, with important impli-cations in evolutionary theory. She has also created model systems for studying complex protein-folding diseases.

Dr. Lindquist’s work also provided the molecular framework to understand a system of protein-based inheritance known as prions. Her work provides critical evidence in support of the revolutionary concept that proteins with altered, self-propagating conformations can transmit genetic information across the generations. Dr. Lindquist’s studies use multiple experimental methods including biochemical, cell biological, and genetic techniques. She also uses multiple organisms including Drosophila, yeast, arabidopsis, and mice to make paradigm-shifting discoveries.

Susan Lindquist is a member and former director of the Whitehead Institute for Biomedical Research, which she guided as the Whitehead Genome Center was transformed into the neighboring Broad Institute. She is also a Howard Hughes Medical Institute Investigator and Professor of Biology at Massachusetts Institute of Technology. She received her Ph.D. in biology from Harvard and was a postdoctoral fellow of the American Cancer Society. She was named the Albert D. Lasker Professor of Medical Sciences in 1999 at the University of Chicago. Dr. Lindquist is an elected member of the National Academy of Sciences and the Institute of Medicine. Her honors also include the Dickson Prize in Medicine, Sigma Xi William Procter Prize for Scientific Achievement, Centennial Medal of the Harvard University Graduate School of Arts and Sciences, Otto-Warburg Prize, and Genetics Society of America Medal.

■■ Pincus AwardIn 1974, FASEB established the Pincus Memorial Fund. The initial gift was given to FASEB by Mrs. Elizabeth N. Pincus to honor her late husband, Gregory G. Pincus, a distinguished physiologist. Thus, the biological community is reminded annually of Dr. Pincus’ distinguished contributions to biology and medicine.

Each year, the President of the Federation has the privilege of naming an individual considered deserving of this recognition. The Pincus Memorial Fund subsidizes the cost of travel, registration, and subsistence for young graduate students preparing for careers in biology and medicine to attend the Experimental Biology Annual Meeting or another scientific meeting of the recipient’s choice.

2009 Pincus award winner laszlo G. nöt

FASEB congratulates Laszlo G. Nöt as the 2009 recipient of the Pincus Award. Dr. Nöt, the 33rd recipient of the award, used his award to attend the

54th Annual Meeting of the Orthopaedic Research Society in February 2009. He stated that the information he learned about new biochemical techniques and novel scientific approaches from the fields of basic and clinical orthopaedic research would be particularly valuable for his career.


Departments, services, and ClientsFaSeB Departments

Executive OfficeGuy Fogleman, Executive DirectorHoward H. Garrison, Deputy Executive Director for PolicyMaureen Murphy, Deputy Executive Director for AdministrationDavid L. Craven, Comptroller

Campus ServicesRichard A. Dunn, DirectorGlen Hutton, Facilities ManagerRita Pumphrey, Production Services Manager

Financial ServicesDavid L. Craven, DirectorDeborah B. Diddle, Professional Accounting Services Manager

Human ResourcesMaureen Murphy, Director

Information TechnologyCaterina Luppi, Director

Managed Society ServicesJohn Lord, Director

Office of MARC and Professional Development ProgramsJacquelyn Roberts, Director

Office of Public AffairsHoward H. Garrison, Director

Office of PublicationsJennifer L. Pesanelli, DirectorEleanor B. Peebles, Dues and Subscriptions Manager

Office of Scientific Meetings and ConferencesMarcella Jackson, Director

FaSeB Services

FASEB has supported scientific societies and biomedical research for almost a century. FASEB provides a variety of logistic and management services to member societies and other nonprofit organizations. Over the years, we have expanded our management expertise and tailored many services to precisely meet the needs of these societies. Our services span a wide range of disciplines and cover everything from day-to-day administration to long-term planning. These include (but are not limited to) full society management; meeting management; accounting; publication and subscription services; information technology; office facilities; human resource management; as well as printing, production, and distribution. Through these various services, FASEB capitalizes on synergy and helps societies to work more efficiently as a group, rather than as individual units. Through sound management practices, FASEB provides societies and their members with more time to focus on what’s most important…science and research.

FaSeB clients

In addition to the FASEB member societies, many other nonprofit organizations benefit from the products and services provided by FASEB departments. In 2009, our clients included:

■▪ Alliance of Hazardous Materials Professionals

■▪ The American Board of Genetic Counseling

■▪ American Board of Medical Genetics■▪ American College of Medical Genetics

■▪ American College of Toxicology■▪ American Psychiatric Publishing, Inc.■▪ American Society for Matrix Biology■▪ American Society of Plant Biologists■▪ American Society for Virology■▪ Association for Psychological Type International

■▪ Association for Research in Vision and Ophthalmology

■▪ The Biophysical Society■▪ Environmental Partners■▪ Experimental Biology 2009■▪ Foundation for the National Institutes of Health

■▪ Genetics Society of America■▪ Health Affairs■▪ The Henry Kunkel Society ■▪ Inflammation Research Association■▪ Institute of Mathematical Statistics■▪ International Energy Agency– Hydrogen Implementing Agreement

■▪ International Society for Advancement of Cytometry

■▪ International Society for Interferon and Cytokine Research

■▪ Life Sciences Research Office■▪ PANLAR Charitable Trust■▪ Protein Data Bank■▪ RNA Society■▪ Society of Biological Inorganic Chemistry

■▪ Society for Leukocyte Biology


2009 financial ReportThe Statement of Financial Position, Statement of Activ-

ities, and Statement of Cash Flow are reproduced on the

following pages. These statements summarize the more

detailed financial statements audited by Tate and Tryon, P.C.

A copy of the financial statements is available upon request

from the Office of the Comptroller. As required by Generally

Accepted Accounting Principles (GAAP), the Federation

reports information regarding its financial position and

activities according to three classes of net assets: unre-

stricted, temporarily restricted, and permanently restricted.

The majority of Federation activities and net assets are

unrestricted and controlled by the Federation Board. The

Federation has adopted Statement of Financial Accounting

Standards (SFAS) 124, which requires that debt and equity

securities be reported at market value. The market value of

investments held by the Federation during 2009 increased

$1,217,714 to a total of $17,174,213. The market value of

investments on December 31, 2008, totaled $15,956,499.

Statement of Financial Position

This statement presents the assets, liabilities, and net

assets of the Federation on December 31, 2009. The net

assets—the difference between assets and liabilities—were

$16,964,228. This represents the accumulated net operating

results of the organization during its history of over 90

years. Investments of $17,174,213 are diversified in cash

and money markets, certificates of deposit, fixed income

mutual funds, equity mutual funds, alternative equity mutual

funds, real estate funds, commodity exchange traded funds

(ETFs), and hedge funds. The Federation has two major

unrestricted investment accounts: the Program Reserve

and the Capital Improvement Reserve. (The Depreciation

Reserve was renamed the Capital Improvement Reserve

to reflect its purpose more accurately.) The Program

Reserve provides financial security in the event of revenue

failure or unanticipated catastrophic emergency, to serve

as a hedge against the outstanding mortgage on the

Federation’s property, and to support operations. The Capital

Improvement Reserve provides for capital improvements,

renovations, and repairs or purchases of major equipment

with a unit price exceeding $5,000. During 2009, the

Federation withdrew $300,000 from the Program Reserve

for operational needs. The Federation anticipates using the

$300,000 during 2010 to fund necessary improvements

in information technology. The other significant asset of


2009 financial Report

the Federation is the net investment of $18,097,123 in

the buildings, grounds, furniture, and equipment on the

Beaumont Campus, home to the Federation, its constituent

societies, and other scientific and educational societies.

Montgomery County’s latest assessment of the value of the

campus buildings and grounds for tax purposes is $30M.

Liabilities totaling $22,453,685 include: amounts owed to

vendors for products and services received; the working

capital credit line totaling $2,300,000; revenue received in

2009 but applicable to programs to be conducted in 2010 of

$701,719; amounts owed to employees under the deferred

compensation plan of $570,026; and building financing

payable to Wachovia Bank for $15,500,000. During 2008,

the State of Maryland issued a variable rate tax-exempt

municipal revenue bond in the amount of $15,500,000

on behalf of the Federation. Of these proceeds from this

bond, $12,440,000 was issued to refund the Series 2002

economic development revenue bonds, and $3,060,000

was issued to finance a portion of the cost of acquisition,

construction, installation, and renovation and equipping

of certain improvements to existing facilities and related

improvements at the headquarters campus, as well as

paying certain costs of issuance of the bond. Wachovia

Bank agreed to guarantee this bond, and it is collateralized

by a letter of credit issued by Wachovia Bank for the same

amount as the bond, plus an additional reserve equal to

34 days accrued interest at a maximum rate of 12%. The

Federation had an undrawn balance from the 2008 project

fund of $1,312,221 as of December 31, 2009. Under the

provisions of the letter of credit agreement, the Federation

made monthly interest-only payments during each of

the years ending December 31, 2009 and 2008. Principal

payments will commence on July 1, 2011, and will continue

until July 1, 2038. The letter of credit has a variable interest

rate calculated by Wachovia Bank in accordance with various

defined terms in its reimbursement and security agreement

with the Federation. The outstanding principal amount

of this letter of credit was $15,500,000 at both December

31, 2009 and 2008. The effective interest rate of the letter

of credit at December 31, 2009 and 2008, was 0.22% and

2.03%, respectively. However, the interest rate paid by the

Federation on the letter of credit is fixed at 3.712% per its

interest rate-swap agreement.


statement of financial Position

Year Ended December 31 2009 2008

ASSETS

Cash and cash equivalents $ 1,638,418 $ 876,495

Investments 16,604,187 15,501,435

Accounts receivable

Trade receivables 329,405 490,510

Government contracts and accounts 181,152 244,003

Member societies and custodial grants 1,527,531 1,859,950

Notes receivable 150,000 150,000

Prepaid expenses 320,071 344,416

Investment held to fund deferred compensation 570,026 455,064

Property and equipment

Land, buildings, and building improvements 25,709,653 25,256,645

Furniture and equipment 3,627,485 3,402,926

Less: accumulated depreciation (11,240,015) (10,731,652)

Net property and equipment 18,097,123 17,927,919

TOTAL ASSETS $ 39,417,913 $ 37,849,792


statement of financial Position


LIABILITIES AND NET ASSETS

LIABILITIES

Accounts payable and accrued expenses $ 851,429 $ 863,785

Deferred revenue 701,719 705,515

Amounts held for member societies and custodial accounts 149,867 159,025

Amounts held for custodial funds from managed meetings 913,504 616,747

Deferred compensation 570,026 455,064

Interest rate-swap agreement 1,467,140 2,604,911

Notes payable—economic development revenue bonds 15,500,000 15,500,000

Notes payable—line of credit 2,300,000 2,300,000

TOTAL LIABILITIES 22,453,685 23,205,047

NET ASSETS

Unrestricted 16,869,205 14,554,075

Temporarily restricted 70,523 66,170

Permanently restricted 24,500 24,500

TOTAL NET ASSETS 16,964,228 14,644,745

TOTAL LIABILITIES AND NET ASSETS $ 39,417,913 $ 37,849,792


statement of activities

Statement of activities

The Statement of Activities covers the 12 months for the

calendar year, ending December 31, 2009, and identifies the

sources of revenue and expense. The financial plan adopted

by the Federation Board required the Board to set a rate for

annual dues paid to the Federation by the member societies.

The dues rate for 2009 was $16 per society member with

minimum dues of $13,000 and a maximum of $155,000 per

society. The accompanying statement shows total revenues

of $18,317,349, including $382,608 of dividends and interest,

$1,567,731 of net realized and unrealized gains (and losses)

on investments, $1,137,771 unrealized gain on the interest

rate-swap agreement, and expenses of $18,707,721. This

resulted in a change in unrestricted net assets of $2,315,130.


statement of activities

Year Ended December 31 2009 2008UNRESTRICTED ACTIVITIESRevenueProgram services

Summer research conferences $ 4,566,008 $ 5,179,508 The Faseb Journal and Directory 2,348,900 2,266,981 MARC program 2,034,519 1,794,918 Career resources 108,448 122,615

Campus and society support services 7,400,959 8,221,036 Core functions 952,106 954,358 General services 464,353 504,310 Investment income 377,881 905,772 Net assets released from restrictions 64,175 86,627 TOTAL UNRESTRICTED REVENUE 18,317,349 20,036,125 ExpenseProgram services

Summer research conferences 4,149,401 4,644,534 MARC program 2,034,519 1,794,918 The Faseb Journal and Directory 1,503,338 1,460,223 Career resources 80,590 107,650

Campus and society support services 7,352,896 7,677,736 Core functions 1,464,758 1,375,436 TOTAL PROGRAM SERVICES 16,585,502 17,060,497 Supporting services

Investment expenses 56,702 51,544 General and administrative 2,065,517 2,204,732

TOTAL SUPPORTING SERVICES 2,122,219 2,256,276 TOTAL EXPENSE 18,707,721 19,316,773

Change in unrestricted net assets before other activities (390,372) 719,352 Net gain (loss) on investments 1,567,731 (5,105,248)Gain (loss) on fair value of interest-swap agreement 1,137,771 (1,942,038)Loss on sale of interest-swap agreement — (146,000)

Change in unrestricted net assets 2,315,130 (6,473,934)Temporarily restricted activities

Contributions 68,440 63,576 Investment income 88 397 Net assets released from restrictions (64,175) (86,627)

Change in temporarily restricted net assets 4,353 (22,654)Change in net assets 2,319,483 (6,496,588)Net assets, beginning of year 14,644,745 21,141,333 NET ASSETS, END OF YEAR $ 16,964,228 $ 14,644,745


statement of Cash flow


CASH FLOW FROM OPERATING ACTIVITIES

Change in net assets $ 2,319,483 $ (6,496,588)

Adjustments to reconcile change in net assets tonet cash provided by (used in) operating activities:

Depreciation and amortization 644,154 756,515

Loss on disposal of property and equipment 16,845 —

Net (gain) loss on investments (1,567,731) 5,105,108

(Gain) loss on fair value of interest-swap agreement (1,137,771) 1,942,038

Loss on sale of interest-swap agreement — 146,000

Changes in assets and liabilities:

Accounts receivable 556,375 (552,811)

Prepaid expenses 24,345 (187,175)

Accounts payable and accrued expenses (12,356) (278,681)

Deferred revenue (3,796) 185,615

Amounts held for member societies and custodial accounts (9,158) (18,605)

Amounts held for custodial funds from managed meetings 296,757 (927,619)

TOTAL ADJUSTMENTS (1,192,336) 6,170,385

Net cash provided by (used in) operating activities 1,127,147 (326,203)

CASH FLOW FROM INVESTING ACTIVITIES

Proceeds from sale of (purchases of ) investments, net 464,979 (2,432,494)

Purchases of property and equipment (830,203) (766,114)

Proceeds from sale of interest rate cap derivative — 1,000

Net cash used in investing activities (365,224) (3,197,608)

CASH FLOW FROM FINANCING ACTIVITIES

Net proceeds from the line of credit — 100,000

Principal payments on the economic development revenue bonds — (12,440,000)

Proceeds from issuance of economic development revenue bonds — 15,500,000

Net cash provided by financing activities — 3,160,000

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 761,923 (363,811)

Cash and cash equivalents, beginning of year 876,495 1,240,306

CASH AND CASH EQUIVALENTS, END OF YEAR $ 1,638,418 $ 876,495

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATIONCash paid during the year for interest $ 645,446 $ 572,486


2009 Revenue and expense

Revenue 2009 ($18.3M)

expense 2009 ($18.7M)

* Includes: Conference Center, Buildings and Grounds,

Production Services, FASEB AdNet, Marketing,

SPCNet, Meetings, Continuing Medical Education, IT,

Accounting, Redactory, Managed Society Services, and

Dues and Subscription Services.

$7.4M

$7.4M

$2.0M

$2.0M

$2.4M

$1.5M

$3.0M

$4.1M

$2.5M

$2.2M

$1.0M

$1.5M

Campus and Society Support Services*

MARC Program

The Faseb Journal and FASEB Directory of Members

Summer Research Conferences

General Services and Investment Income

Core Functions

Campus and Society Support Services*

MARC Program

The Faseb Journal and FASEB Directory of Members

Summer Research Conferences

General Services and Investment Income

Core Functions


about faseb Member societies

Founded in 1912, the Federation of american Societies for experimental Biology (FaSeB) was originally created by three independent scientific organizations to provide a forum in which to hold educational meetings, develop publications, and disseminate biological research results. what started as a small group of dedicated scientists has grown to be the nation’s largest coalition of biomedical researchers, representing 21 scientific societies and over 90,000 researchers from around the world in 2009. FaSeB is now recognized as the voice of advocacy for biological and biomedical research scientists.

tHe aMerican PHySioloGical Society—aPS

Founded: 1887 Founding Member of FASEB: 1912Mission: The American Physiological Society is devoted to fostering scientific research, education, and the dissemi-nation of scientific information. By providing a spectrum of physiological information, the society strives to play a role in the progress of science and the advancement of knowledge. Providing current, usable information to the physiological community is the society’s primary focus.President: Gary C. Sieck, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, MinnesotaExecutive Director: Martin FrankMembership: 10,500Website: www.the-aps.org

aMerican Society For BiocHeMiStry anD Molecular BioloGy—aSBMB

Founded: 1906 Founding Member of FASEB: 1912 Mission: The society’s purpose is to advance the science of biochemistry and molecular biology through publication of scientific and educational journals: Journal of biological

Chemistry, Molecular & Cellular Proteomics, and Journal of Lipid

Research; organization of scientific meetings; advocacy for funding of basic research and education; support of science education at all levels; and promoting the diversity of indi-viduals entering the scientific workforce.

President: Gregory A. Petsko, Departments of Chemistry & Biochemistry, Brandeis University, Rosenstiel Center, Waltham, MassachusettsExecutive Director: Barbara A. GordonMembership: 11,600Website: www.asbmb.org

aMerican Society For PHarMacoloGy anD exPeriMental tHeraPeuticS—aSPet

Founded: 1908 Founding Member of FASEB: 1912Mission: The society’s purpose is to promote the advancement of the sciences of pharmacology and experi-mental therapeutics and to facilitate the interchange of information between investigators who are engaged in research in those fields by organizing scientific meetings, publishing journals, and engaging in other activities that advance the discipline.President: Brian M. Cox, Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, MarylandExecutive Director: Christine K. CarricoMembership: 4,800Website: www.aspet.org


aMerican Society For inveStiGative PatHoloGy —aSiP

Founded: 1900 Member of FASEB: 1913Mission: The mission of the society is to promote the discovery, advancement, and dissemination of basic and translational knowledge in experimental pathology and related disciplines. This shall be achieved by fostering inves-tigation into the pathogenesis, classification, diagnosis, and manifestations of disease through meetings, publications, and educational activities.President: Stanley Cohen, Department of Pathology and Laboratory Medicine, UMDNJ–New Jersey Medical School, Newark, New JerseyExecutive Director: Mark E. SobelMembership: 2,000Website: www.asip.org

aMerican Society For nutrition—aSn

Founded: 1928 Member of FASEB: 1940Mission: The mission of the society is to develop and extend knowledge of nutrition of all species through fundamental, multidisciplinary, and clinical research; facilitate contact among investigators in nutrition, medicine, and related fields of interest; support the dissemination and application of nutrition science to improve public health and clinical practice worldwide; promote graduate education and training of physicians in nutrition; provide reliable nutrition information to those who need it; and advocate for nutrition research and its application to development and implemen-tation of policies and practices related to nutrition.

President: James O. Hill, University of Colorado Health Science Center, Denver, ColoradoExecutive Director: John E. CourtneyMembership: 3,900 Website: www.nutrition.org

tHe aMerican aSSociation oF iMMunoloGiStS —aai

Founded: 1913 Member of FASEB: 1942Mission: The American Association of Immunologists is an association of professionally trained scientists dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and infor-mation among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues.President: Betty Diamond, Center for Autoimmune and Musculoskeletal Disorders, The Feinstein Institute for Medical Research, North Shore–LIJ Health System, Manhasset, New YorkExecutive Director: M. Michele Hogan Membership: 6,800Website: www.aai.org

aMerican aSSociation oF anatoMiStS—aaa

Founded: 1888 Member of FASEB: 1993Mission: Via research, education, and professional development, the American Association of Anatomists promotes the three-dimensional understanding of structure as it relates to development and function, from molecule to organism.President: Kathryn J. Jones, Department of Microbiology and Immunology, Loyola University, Stritch School of Medicine, Maywood, IllinoisExecutive Director: Andrea Pendleton Membership: 1,800Website: www.anatomy.org


tHe Protein Society—PS

Founded: 1986 Member of FASEB: 1995Mission: The Protein Society is the leading international society devoted to furthering research and development in protein science. Our mission is to bring together scientific disciplines from around the world in international forums to facilitate communication, cooperation, and collaboration with respect to all aspects of the study of proteins. In support of these goals, the society also publishes Protein science, the premier journal in the field.President: Daniel Raleigh, Department of Chemistry, State University of New York at Stony Brook, Stony Brook, New YorkExecutive Officer: Cynthia A. YablonskiMembership: 2,000Website: www.proteinsociety.org

Society For DeveloPMental BioloGy—SDB

Founded: 1939 Member of FASEB: 1996Mission: The purpose of the society is to further the study of development in all organisms and at all levels and to represent and promote communication among students of development.President: Richard Harland, Department of Molecular and Cell Biology, University of California, Berkeley, CaliforniaExecutive Director: Ida ChowMembership: 2,400Website: www.sdbonline.org

aMerican PePtiDe Society—aPePS

Founded: 1990 Member of FASEB: 1996Mission: The purpose of the society is to advance and promote the knowledge of the chemistry and biology of peptides and proteins.President: Gregg B. Fields, Department of Biochemistry, The University of Texas Health Science Center, San Antonio, TexasMembership: 900Website: ampepsoc.org

aSSociation oF BioMolecular reSource FacilitieS—aBrF

Founded: 1988 Member of FASEB: 1997Mission: The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication, and education.

President: Michelle Detwiler, Roswell Park Cancer Institute, Buffalo, New YorkMembership: 600Website: www.abrf.org

tHe aMerican Society For Bone anD Mineral reSearcH—aSBMr

Founded: 1977 Member of FASEB: 1997 Mission: The American Society for Bone and Mineral Research is a professional, scientific, and medical society established to promote excellence in bone and mineral research, to foster integration of basic and clinical science, and to facilitate the translation of that science to health care and clinical practice. Key objectives to achieve these goals include the nurturing and development of future genera-tions of basic and clinical scientists and the dissemination of new knowledge in bone and mineral metabolism. The American Society for Bone and Mineral Research is proactive in shaping research and health policies based on scientific advances in our field.President: Jane B. Lian, Department of Cell Biology, University of Massachusetts Medical School, Worcester, MassachusettsExecutive Director: Ann L. ElderkinMembership: 3,800Website: www.asbmr.org

aMerican Society For clinical inveStiGation —aSci

Founded: 1908 Member of FASEB: 1998Mission: The American Society for Clinical Investigation is an honor society of physician-scientists representing all disciplines of medical science. Members are elected based on the quality and impact of their research and their overall contributions to the biomedical research community. The society seeks to particularly recognize physician-scientists doing novel, creative, rigorous, and reproducible research,


which is based on a solid foundation of science and likely to stand the test of time. ASCI is organized and operated exclusively for educational and scientific purposes. In furthering these aims, the society convenes an annual meeting and publishes The Journal of Clinical Investigation, both of which highlight high-impact work from a broad range of disciplines.President: Jonathan Epstein, University of Pennsylvania School of Medicine, Philadelphia, PennsylvaniaExecutive Director: John B. Hawley Membership: 3,000 Website: www.the-asci.org

Society For tHe StuDy oF reProDuction—SSr

Founded: 1967 Member of FASEB: 1998Mission: The mission of the society is to promote the study of reproduction by fostering interdisciplinary commu-nication among scientists, holding conferences, and publishing meritorious studies.President: John H. Nilson, School of Molecular Biosciences, Washington State University, Pullman, Washington Executive Director: Judith JansenMembership: 2,200Website: www.ssr.org

teratoloGy Society—tS

Founded: 1960 Member of FASEB: 1998Mission: The mission of the society is to promote research and the exchange of ideas and research results that reveal the causes, improve the diagnosis and treatment, and prevent the occurrence of abnormal development and birth defects; to communicate that information to physicians, public health officials, concerned health advocacy and

lay groups, and other interested parties who promote the elimination of birth defects when possible and amelioration of them when they occur; and to provide education and training about the causes, mechanisms, treatment, and prevention of birth defects.President: Barbara F. Hales, McGill University, Montreal, Quebec, CanadaExecutive Director: Tonia MassonMembership: 700Website: www.teratology.org

tHe enDocrine Society—teS

Founded: 1916 Member of FASEB: 1999Mission: The Endocrine Society’s mission is to advance excel-lence in endocrinology and promote its essential role as an integrative force in scientific research and medical practice.President: Robert A. Vigersky, Walter Reed Health Care System, Washington, D.C.Executive Director: Scott HuntMembership: 14,500Website: www.endo-society.org

tHe aMerican Society oF HuMan GeneticS—aSHG

Founded: 1948 Member of FASEB: 1999Mission: The American Society of Human Genetics serves research scientists, health professionals, and the public by enabling its members to: share research results at annual meetings and publish in The american Journal of Human

Genetics; advance genetic research by advocating for research support; enhance genetics education by preparing future professionals and informing the public; promote genetic services; and support responsible social and scientific policies.President: Edward R. B. McCabe, David Geffen School of Medicine, University of California, Los Angeles, CaliforniaExecutive Director: Joann A. BoughmanMembership: 7,500Website: www.ashg.org

environMental MutaGen Society—eMS

Founded: 1969 Member of FASEB: 2001Mission: The Environmental Mutagen Society’s mission is: 1) to foster scientific research and education about the causes and mechanistic bases of DNA damage and repair, muta-genesis, heritable effects, epigenetic alterations in genome


function, and their relevance to disease and 2) to promote the application and communication of this knowledge to genetic toxicology testing, risk assessment, and regulatory policymaking to protect human health and the environment. President: Michael J. Plewa, Department of Crop Sciences and Water CAMPWS NSF Center, University of Illinois at Urbana, Urbana, IllinoisExecutive Director: Tonia MassonMembership: 500Website: www.ems-us.org

international Society For coMPutational BioloGy—iScB

Founded: 1996 Member of FASEB: 2003Mission: The International Society for Computational Biology is a scholarly society dedicated to advancing the scientific understanding of living systems through computation. The society communicates the significance of our science to the larger scientific community, governments, and the public at large. The International Society for Computational Biology serves a global membership by impacting government and scientific policies, providing high-quality publications and meetings, and distributing valuable information about training, education, employment, and relevant news from related fields.

President: Burkhard Rost, Department of Biochemistry and Molecular Biophysics, and Center for Computational Biology, Columbia University, New York, New YorkExecutive Officer: BJ Morrison McKayMembership: 2,500 Website: www.iscb.org

aMerican colleGe oF SPortS MeDicine—acSM

Founded: 1954 Member of FASEB: 2005Mission: The American College of Sports Medicine promotes and integrates scientific research, education, and practical applications of sports medicine and exercise science to maintain and enhance physical performance, fitness, health, and quality of life.President: James Pivarnik, Michigan State University, East Lansing, MichiganExecutive Vice President: James R. WhiteheadMembership: 20,000Website: www.acsm.org

BioMeDical enGineerinG Society—BMeS

Founded: 1968 Member of FASEB: 2009Mission: The mission of the society is to promote and enhance biomedical engineering knowledge worldwide and its use for the health and well-being of humankind.President: George Truskey, Department of Biomedical Engineering, Duke University, Durham, North CarolinaExecutive Director: Edward L. Schilling IIIMembership: 3,900Website: www.bmes.org

Information reported as of December 31, 2009

http://www.bmes.org


9650 Rockville PikeBethesda, MD 20814301.634.7000 [email protected]

FASEB Annual Report 2009

CreditsThank you to those who contributed to the production

of this annual report.

Contributors■▪ David Craven, Comptroller, FASEB Financial Services

■▪ Richard Dunn, Director, FASEB Campus Services

■▪ Guy Fogleman, Executive Director, FASEB Executive Office

■▪ Howard Garrison, Deputy Executive Director for Policy, FASEB Executive Office; Director, FASEB Office of Public Affairs

■▪ Jennifer Hobin, Associate Director for Scientific Affairs, FASEB Office of Public Affairs

■▪ Julie Levin, Manager, FASEB Summer Research Conferences

■▪ Jennifer Pesanelli, Director, FASEB Office of Publications

■▪ Jacquelyn Roberts, Director, FASEB MARC and Professional Development Programs

■▪ Linda Stricker, Sr. Executive Assistant, FASEB Executive Office

■▪ Gerald Weissmann, Editor-in-Chief, The Faseb Journal

■▪ Carrie Wolinetz, Director of Scientific Affairs and Public Relations, FASEB Office of Public Affairs

Copy Editor■▪ Becki Weiss, Copy Editor

Proofreaders■▪ Gail Fallon, Production Manager, FASEB Office of Publications

■▪ Ruth Grunspan, Sr. Annual Publications Editor, FASEB Office of Publications

Design■▪ Communicate By Design www.communicatebydesign.com

Printer■▪ Rita Pumphrey, Manager, FASEB Production Services

Project Manager■▪ Veronica Purvis, Advertising/Marketing Manager, FASEB Office of Publications

mailto:[email protected]


http://www.communicatebydesign.com

9650 Rockville PikeBethesda, MD 20814301.634.7000 [email protected]


This report is printed on recycled paper.



2009 annual report - faseb...faseb is a 501(c)(3) tax exempt organization of multiple member...

Documents